United States

Hofseth Biocare ASA (HOFBC.OL)

HOFBC.OL on Oslo Stock Exchange

Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Hofseth Biocare to sell and lease contracts of properties
Friday, 3 Mar 2017 05:50am EST 

Hofseth Biocare ASA : To sell and lease company's property at Midsund . HBC Berkåk as entered into an agreement for sale and lease of property at Berkåk . Says plants are sold for a joint consideration of 80 million Norwegian crowns ($9.5 million), of which 51.5 million crowns is payable for Midsund plant and 28.5 million crowns is payable for Berkåk plant . Agreements are entered into with Syvde Eiendom, a wholly owned subsidiary of major shareholder alliance Seafoods Inc . Says shall enter into a 15-year lease agreement regarding midsund property with an annual lease sum of 4,635,000 crowns .Says HBC Berkåk shall enter into a lease agreement for Berkåk property with same term and with an annual lease sum of 2,565,00 crowns.  Full Article

Hofseth Biocare Q3 EBITDA loss widens to NOK 41.2 mln
Friday, 18 Nov 2016 01:34am EST 

Hofseth Biocare : Reported on Thursday Q3 operating revenues of 3.6 million Norwegian crowns ($420,000) versus 16.6 million crowns year ago . Q3 EBITDA loss 41.2 million crowns versus loss 11.5 million crowns .Q3 operating expenses amounted to 49.2 million crowns (32.3 million crowns year ago), including inventory write-offs of 25.9 million crowns.  Full Article

Hofseth Biocare receives patent in the European Union
Wednesday, 5 Oct 2016 06:57am EDT 

Hofseth Biocare ASA :Announces grant of its European patent application no. 08861633.9 for compositions and methods for increasing iron absorption.  Full Article

Hofseth biocare announces equity issue of minimum NOK 165 mln
Monday, 29 Aug 2016 02:00am EDT 

Hofseth Biocare ASA : Announces an equity issue of minimum 165 million Norwegian crowns ($20 million) at a subscription price of 1.50 per share crown . Cash equity issue of minimum 59 million crowns towards Alliance Seafoods Inc. and certain shareholders of which Alliance Seafoods will subscribe for 50 million crowns . Buy-back of all outstanding convertible bonds by issuing new shares worth about 75.3 million crowns based on subscription price .Board will propose a subsequent offering up to 20 million crowns to limit dilutive effect of equity issue..  Full Article

Hofseth Biocare Q2 operating loss widens to NOK 47.5 million
Monday, 29 Aug 2016 02:00am EDT 

Hofseth Biocare ASA : Q2 operating revenue 8.2 million Norwegian crowns ($989,848) versus 6.4 million crowns year ago . Q2 operating loss 47.5 million crowns versus loss 19.1 million crowns year ago .Expects to recognize significant negative one-off items during q3.  Full Article

Hofseth Biocare: OmeGo patent notice of allowance in US and new study on ProGo
Tuesday, 2 Aug 2016 02:53am EDT 

Hofseth Biocare ASA : US patent office has issued a Notice of Allowance on one of HBC's key licensed-in salmon oil patent applications . Grant of this patent will allow HBC to bolster its marketing for improved heart health with a unique and proprietary mechanism of action now with patent protection in largest nutraceutical market in world .Trial shows that even small doses of ProGo will stimulate energy and vitality in normal individuals.  Full Article

Hofseth Biocare cancels subsequent offering
Thursday, 26 May 2016 07:24am EDT 

Hofseth Biocare ASA : Board of Directors decided to withdraw its proposal for subsequent offering .Says the company's existing shareholders have been able to neutralize dilutive effect of share issue, which was adopted on April 22, by buying shares in open market at price below subscription price of 2.00 Norwegian crowns per share.  Full Article

Hofseth BioCare Q1 EBIT widening to NOK 25.5 million
Monday, 23 May 2016 01:46am EDT 

Hofseth BioCare ASA : Said on Friday operating revenues of 5.4 million Norwegian crowns ($650,000) was in the first quarter of 2016, in line with the first quarter of 2015 .Q1 operating profit (EBIT) was negative 25.5 million crowns, compared to negative 18.6 million in the same quarter last year.  Full Article

Hofseth Biocare ASA completes private placement
Friday, 22 Apr 2016 12:00pm EDT 

Hofseth Biocare ASA:Completed private placement of 23.6 million Norwegian crowns towards certain existing shareholders and external investors through issuance of 11.8 million new shares at subscription price of 2 crowns per share.Raised about 12.9 million crowns in cash and about 10.7 million crowns through conversion of debt.  Full Article

Hofseth Biocare starts selling products in XXL
Wednesday, 20 Apr 2016 08:25am EDT 

Hofseth Biocare ASA:Hofseth BioCares ASA has today signed an agreement with XXL GrossistNorge AS and XXL Europe GmbH for the deliveies of a variety of finished products for sale in Norway, Sweden and Finland.Deliveries to XXL starts during summer of 2016 and will be in stores XXLs immediately thereafter.Final size of contract is still uncertain and will depend on sales volumes in three countries.  Full Article

BRIEF-Hofseth Biocare to sell and lease contracts of properties

* HBC Berkåk as entered into an agreement for sale and lease of property at Berkåk